Drug-eluting bioabsorbable stents - An in vitro study

Acta Biomaterialia

Volumn 5, Issue 8, 2009, Pages 2894-2900

  Mikkonen, J ^a   Uurto, I ^b   Isotalo, T ^c   Kotsar, A ^b   Tammela, T L J ^b   Talja, M ^c   Salenius, J P ^b   Tormala P ^a   Kellomaki M ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

Author keywords

Bioabsorbable; Coating; Drug elution; In vitro; Stent

Indexed keywords

ACETONE; ANTIBIOTICS; DRUG DOSAGE; LACTIC ACID; SODIUM COMPOUNDS;

BIOABSORBABLE; DEXAMETHASONES; DRUG ELUTION; ELUTION PROFILES; GAMMA STERILIZATION; IN-VITRO; INDOMETHACIN; PROPERTY; SIMVASTATIN; VITRO STUDIES;

STENTS;

ACETONE; CIPROFLOXACIN; DEXAMETHASONE; INDOMETACIN; POLYLACTIC ACID; SIMVASTATIN; SODIUM CHLORIDE;

ARTICLE; CONCENTRATION PROCESS; DRUG ELUTING STENT; ELUTION; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; MATERIAL COATING; PRIORITY JOURNAL; RADIATION STERILIZATION; SPECTROPHOTOMETER;

ABSORBABLE IMPLANTS; ABSORPTION; ANTI-INFLAMMATORY AGENTS; BIOCOMPATIBLE MATERIALS; DIFFUSION; DRUG-ELUTING STENTS; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; MATERIALS TESTING;

EID: 70349145865     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2009.03.039     Document Type: Article

References (25)

1. Babapulle M., and Eisenberg M. Coated stents for the prevention of restenosis: part II. Circulation 106 (2002) 2734-2859
2. Damiano R., Autorino R., Esposito C., Cantiello F., Sacco R., and de Sio M. Stent positioning after ureteroscopy for urinary calculi: the question is still open. Eur Urol 246 (2004) 381-388
3. Eberhart R., Su S.-H., Nguyen K., Zilberman M., Tang L., Nelson K., et al. Bioresorbable polymeric stents: current status and future promise. J Biomater Sci Polym Edn 14 (2003) 299-312
4. Lam J., and Gupta M. Update on ureteral stents. Urology 64 (2004) 9-15
5. Isotalo T., Talja M., Hellström P., Perttilä I., Välimaa T., Törmälä P., et al. A double-blind, randomized, placebo-controlled pilot study to investigate the effects of finasteride combined with a bioabsorbable self-reinforced poly-l-lactic acid spiral stent in patients with urinary retention caused by bladder outlet obstruction from benign prostatic hyperplasia. BJU Int 88 (2001) 30-34
6. Multanen M., Tammela T., Laurila M., Seppälä J., Välimaa T., Törmälä P., et al. Biocompatibility, encrustation and biodegradation of ofoxacine and silver nitrate coated poly-l-lactic acid stents in rabbit urethra. Urol Res 30 (2002) 227-232
7. van der Giessen W., Lincoff A., Schwartz R., van Beusekom H., Serruys P., and Holmes D. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 94 (1996) 1690-1697
8. Tsuji T., et al. Biodegradable stent as a platform to drug loading. Int J Cardiovasc Intervent 5 (2003) 13-16
9. Uurto I., et al. Drug-eluting biodegradable poly-d/l-lactic acid vascular stents: an experimental pilot study. J Endovasc Ther 12 (2005) 371-379
10. Isotalo T., Alarakkola E., Talja M., Tammela T., Välimaa T., and Törmälä P. Biocompatibility testing of a new bioabsorbable X-ray positive SR-PLA 96/4 urethral stent. J Urol 162 (1999) 1764-1767
11. Lewis A., et al. Phosphorylcholine-based polymer coatings for stent drug delivery. J Mater Sci: Mater Med 12 (2001) 865-870
12. Lincoff A., Furst J., Ellis S., Tuch R., and Topol E. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J Am Coll Cardiol 29 (1997) 808-816
13. Strecker E.-P., et al. Effect on intimal hyperplasia of dexamethasone released from coated metal stents compared with non-coated stents in canine femoral arteries. Cardiovasc Intervent Radiol 21 (1998) 487-496
14. Yoon J., Kim J., and Park T. Dexamethasone-releasing biodegradable polymer scaffolds fabricated by a gas-foaming/salt-leaching method. Biomaterials 24 (2003) 2323-2329
15. Hoffmann R., et al. Evaluation of a high-dose dexamethasone-eluting stent. Am J Cardiol 94 (2004) 193-195
16. Han S., et al. The favorable clinical and angiographic outcomes of a high-dose dexamethasone-eluting stent: randomized controlled prospective study. Am Heart J 152 (2006) 887.e1-887.e7
17. Indolfi C., et al. Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury. J Am Coll Cardiol 35 (2000) 214-221
18. Curcio A., et al. Coated stents: a novel approach to prevent in-stent restenosis. Ital Heart J 3 (2002) 16S-19S
19. Naber K., and Landen H. Rapid resolution of symptoms with ciprofloxacin therapy in 3859 hospitalised patients with urinary tract infection. Int J Antimicro Ag 23 (2004) S35-S40
20. Reid G., Habash M., Vachon D., Denstedt J., Riddell J., and Beheshti M. Oral fluoroquinolone therapy results in drug adsorption on ureteral stents and prevention of biofilm formation. Int J Antimicro Ag 17 (2001) 317-320
21. Tanaka K., Tanaka H., Kanemoto Y., and Tsuboi I. The effects of nonsteroidal anti-inflammatory drugs on immune functions of human peripheral blood mononuclear cells. Immunopharmacology 140 (1998) 209-217
22. Bartolotta A., et al. Effects of gamma-irradiation on trehalose-hydroxyethylcellulose microspheres loaded with vancomycin. Eur J Pharmaceut Biopharmaceut 59 (2005) 139-146
23. Calis S., Bozdag S., Süheyla Kas H., Tunkay M., and Atilla Hincal A. Influence of irradiation sterilization on poly(lactide-co-glycolide) microspheres containing anti-inflammatory drugs. Il Farmaco 57 (2002) 55-62
24. Maggi L., Segale L., Ochoa M.e., Faucitano A., Buttafava A., and Conte U. Polymer-gamma ray interaction. Effects of gamma irradiation on modified release drug delivery systems for oral administration. Int J Pharm 269 (2004) 343-351
25. Yoshioka S., Aso Y., and Kojima S. Drug release from poly(dl-lactide) microspheres controlled by γ-irradiation. J Control Release 37 (1995) 263-267